CONDUCTink is a biotechnology company that develops materials to both model and regenerate the central nervous system. Our mission is to support researchers and patients by creating platforms that accelerate Alzheimer's drug discovery and produce regenerative strategies to repair spinal cord injury. We strive to discover breakthrough in the treatment of nuerodegenerative disease and injury through our workflows in biomaterial synthesis.